| Code | 2403B | ||||||||||
| MA number | 01/0394/14-S | ||||||||||
| Product Form: | sol inj 10x2 ml/40 mg (amp.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Egis Pharmaceuticals PLC, Hungary | ||||||||||
| Therapeutic Class: | 01 - ANAESTHETICA (LOKÁLNE) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass ampoule | ||||||||||
| Route of admin.: | Intravenous and epidural use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 17.12.2014 |
| Pediatric posology: | Yes |
| PIL: |
PIL_Lidocain EGIS inj _01_2021.doc
|
| SPC: |
SPC_Lidocain EGIS_02_2024.pdf
|
| Safety feature | Yes |
| Data update: | 08.02.2024 |
